Synthetic estrogens-mediated activation of JNK intracellular signaling molecule

References

• Davis RJ. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 1993; 268:14553–6
   PubMed Web of Science ®Google Scholar
• Roudabush FL, Pierce KL, Maudsley S, et al. Transactivation of the EGF receptor mediates IGF-1-stimulated Shc phosphorylation and ERK1/2 activation in COS-7 cells. J Biol Chem 2000;275:22583–9
   PubMed Web of Science ®Google Scholar
• Cruzalegui FH, Cano E, Treisman R. ERK activation induces phosphorylation of Elk-1 at multiple S/T-P motif to high stoichiometry. Oncogene 1999;18: 7948–57
   Google Scholar
• Minden A, Karin M. Regulation and function of the JNK subgroup ofMAP kinases. Biochim Biophys Acta 1997;1333:85–104
   PubMed Web of Science ®Google Scholar
• Chen Q, Kinch MS, Lin TH, et al. Integrin-mediated cell adhesion activates mitogen-activated protein kinases. J Biol Chem 1994;269:26602–5
   PubMed Web of Science ®Google Scholar
• Kyriakis JM, Baneijee P, Nikolakaki E, et al. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 1994;369:156–60
   PubMed Web of Science ®Google Scholar
• Hibi M, Lin A, Smeal T, et al. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev 1993;7:2135–48
   PubMed Web of Science ®Google Scholar
• Minden A, Lin A, Smeal T, et al. c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases. Mol Cell Biol 1994;14:6683–8
   PubMedGoogle Scholar
• Sluss HK, Barrett T, Derijard B, et al. Signal transduction by tumor necrosis factor mediated by JNK protein kinases. Mol Cell Biol 1994; 14:8376–84
   PubMed Web of Science ®Google Scholar
• Coso OA, Chiariello M, Yu JC, et al. The small GTP-binding proteins Rac 1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell 1995;81:1137–46
   PubMed Web of Science ®Google Scholar
• Blank JL, Gerwins P, Elliott EM, et al. Molecular cloning of mitogen-activated protein/ERK kinase kinases (MEKK) 2 and 3. Regulation of sequential phosphorylation pathways involving mitogen-activated protein kinase and c-Jun kinase. J Biol Chem 1996;271:5361–8
   Google Scholar
• Natoli G, Costanzo A, Ianni A, et al. Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science 1997;275:200–3
   PubMed Web of Science ®Google Scholar
• Kallunki T, Deng T, Hibi M, et al. c-Jun can recruit JNK to phosphorylate dimerization partners via specific dockinginteractions. Cell 1996;87:929–39
   PubMedGoogle Scholar
• Gupta S, Campbell D, Derijard B, et al. Trans-cription factor ATF2 regulation by the JNK signal transduction pathway. Science 1995;267:389–93
   PubMed Web of Science ®Google Scholar
• Agadir A, Chen Gq, Bost F, etal. Differential effect of retinoic acid on growth regulation by phorbol ester in human cancer cell lines. J Biol Chem 1999;274:29779–85
   Google Scholar
• Frey RS, Mulder KM. Involvement ofextracellular signal-regulated kinase 2 and stress-activated protein kinase/Jun N-terminal kinase activation by transforming growth factor beta in the negative growth control of breast cancer cells. Cancer Res 1997;57:628–33
   PubMedGoogle Scholar
• Huang Y, Sheikh MS, Fornace AJ Jr, et al. Serine protease inhibitor TPCK prevents Taxol-induced cell death and blocks c-Raf-1 and Bc1-2 phosphorylation in human breast carcinoma cells. Oncogene 1999;18:3431–9
   PubMed Web of Science ®Google Scholar
• Sakata N, Patel HR, Terada N, et al. Selective activation of c-Jun kinase mitogen-activated protein kinase by CD40 on human B cells. J Biol Chem 1995;270:30823–8
   PubMed Web of Science ®Google Scholar
• Kelsey JL, Gammon MD. Epidemiology of breast cancer. Epidemiol Rev 1990;12:228–40
   PubMedGoogle Scholar
• Migliaccio A, Di Domenico M, Castoria G, et al. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol—receptor complex in MCF-7 cells. EMBO J1996;15:1292–300
   PubMed Web of Science ®Google Scholar
• Lange CA, Richer JK, Horwitz KB. Hypothesis: Progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals. Mol Endocrinol 1999;13:829–36
   Google Scholar
• Srivastava S, Weitzmann MN, Cenci S, et al. Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD.J Clin Invest 1999;104:503–13
   PubMed Web of Science ®Google Scholar
• Gentry MK, Dalrymple JM. Quantitative micro-titer cytotoxicity assay for Shigella toxin. J Clin Microbiol 1980;12:361–6
   PubMedGoogle Scholar
• Kenney NJ, Dickson RB. Growth factor and sex steroid interactions in breast cancer. J Mammary Gland Biol Neoplasia 1996;1:189–98
   Google Scholar
• Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replace-ment therapy: collaborative reanalysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108411 women without breast cancer. Lancet 1997;350:1047–59
   PubMed Web of Science ®Google Scholar
• Pike M, Henderson BE, Krailo MD, et al. Breast cancer in young women and use of oral contra-ceptives: possible modifying effect of formulation and age at use. Lancet 1983;2:926–9
   PubMed Web of Science ®Google Scholar
• Iacopino F, Ferrandina G, Scambia G, et al. Inter-ferons inhibit EGF-stimulated cell growth and reduce EGF binding in human breast cancer cells. Anticancer Res 1996;16:1919–24
   Google Scholar
• Kasid A, Lippman ME. Estrogen and oncogene mediated growth regulation of human breast cancer cells. J Steroid Biochem 1987;27:465–70
   PubMedGoogle Scholar
• Jordan VC, ed. Estrogen-antiestrogen Action and Breast Cancer Therapy. Madison: University of Wisconsin Press, 1986:132–43
   Google Scholar
• Santen RJ, Manni A, Harvey H, et al. Endocrine treatment of breast cancer in women. Endocr Rev 1990;11:221–65
   PubMed Web of Science ®Google Scholar
• Nuedling S, Kahlert S, Loebbert K, et al. Differ-ential effects of 17beta-estradiol on mitogen-activated protein kinase pathways in rat cardio-myocytes. FEBS Lett 1999;454:271–6
   Google Scholar
• Wu CJ, Qian X, O'Rourke DM. Sustained mitogen-activated protein kinase activation is induced by transforming erbB receptor complexes. DNA Cell Biol 1999;18:731–41
   Google Scholar
• Bost F, McKay R, Bost M, et al. The Jun kinase 2 isoform is preferentially required for epidermal growth factor-induced transformation of human A549 lung carcinoma cells. Mol Cell Biol 1999;19:1938–49
   PubMed Web of Science ®Google Scholar
• Roncero C, Ventura .11, Sanchez A, et al. Phorbol esters down-regulate alpha-fetoprotein gene expression without affecting growth in fetal hepatocytes in primary culture. Biochim Biophys Acta 1998;1402:151–64
   Google Scholar